- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 32.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 32.68M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 32.7M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $7.41M |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $3.25M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $236K |
| Capex | Q1 2026 · Mar 31, 2025 | $105K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.54M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $6.98M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $34.22M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $33.83M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $411.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $399.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $577.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $576.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $531.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $511.84M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.47B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.46B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.05B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.03B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.42 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.52 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.43 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.52 |
| Net Income | Q1 2026 · Mar 31, 2026 | $13.79M |
| Net Income | Q1 2026 · Mar 31, 2025 | $16.85M |